We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$106B
AUM Growth
+$3.62B
Cap. Flow
-$1.47B
Cap. Flow %
-1.39%
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$281M
2
AMZN icon
Amazon
AMZN
+$228M
3
TWX
Time Warner Inc
TWX
+$219M
4
LLY icon
Eli Lilly
LLY
+$212M
5
RTX icon
RTX Corp
RTX
+$208M

Sector Composition

Rank Sector Weight
1 Financials 16.44%
2 Healthcare 15.11%
3 Industrials 11.28%
4 Energy 10.95%
5 Technology 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNA icon
701
CNA Financial
CNA
$14.5B
$12.7M 0.01%
313,390
-3,844
-1% -$158K
DATA
702
DELISTED
Tableau Software, Inc.
DATA
$12.6M 0.01%
176,717
+9,856
+6% +$618K
ACAD icon
703
Acadia Pharmaceuticals
ACAD
$4.25B
$12.6M 0.01%
556,436
-28,105
-5% -$587K
HF
704
DELISTED
HFF Inc.
HF
$12.6M 0.01%
337,848
+105,662
+46% +$3.52M
GPK icon
705
Graphic Packaging
GPK
$3.26B
$12.5M 0.01%
1,069,477
-66,281
-6% -$710K
INSY
706
DELISTED
Insys Therapeutics, Inc.
INSY
$12.5M 0.01%
799,326
+511,150
+177% +$8.26M
CMS icon
707
CMS Energy
CMS
$23.1B
$12.5M 0.01%
400,628
-105
-0% -$3.13K
OMG
708
DELISTED
OM GROUP INC.
OMG
$12.4M 0.01%
383,673
-7,226
-2% -$223K
ESL
709
DELISTED
Esterline Technologies
ESL
$12.4M 0.01%
107,891
-31,952
-23% -$3.53M
PBH icon
710
Prestige Consumer Healthcare
PBH
$2.35B
$12.4M 0.01%
366,019
+167,894
+85% +$5.38M
VOYA icon
711
Voya Financial
VOYA
$8.94B
$12.3M 0.01%
339,223
-597,971
-64% -$21.4M
YHOO
712
PUT
DELISTED
Yahoo Inc
YHOO
$12.3M 0.01%
+350,000
New +$12.2M
PGTI
713
DELISTED
PGT, Inc.
PGTI
$12.2M 0.01%
1,443,504
+2,854
+0.2% +$26.6K
IEX icon
714
IDEX
IEX
$16.5B
$12.2M 0.01%
151,308
EME icon
715
Emcor
EME
$33.1B
$12.2M 0.01%
273,821
+3,012
+1% +$137K
UMPQ
716
DELISTED
Umpqua Holdings Corp
UMPQ
$12.2M 0.01%
678,960
-49,393
-7% -$858K
ZTS icon
717
Zoetis
ZTS
$31.6B
$12.1M 0.01%
374,144
-177,267
-32% -$5.44M
BRS
718
DELISTED
Bristow Group, Inc.
BRS
$12.1M 0.01%
149,733
+16,219
+12% +$1.23M
MOS icon
719
The Mosaic Company
MOS
$7.09B
$12.1M 0.01%
244,092
-215
-0.1% -$10.6K
OSK icon
720
Oshkosh
OSK
$9.67B
$12M 0.01%
216,529
-1,740
-0.8% -$96.2K
ACN icon
721
Accenture
ACN
$89.9B
$12M 0.01%
148,349
-1,619
-1% -$130K
INFA
722
DELISTED
INFORMATICA CORP
INFA
$12M 0.01%
336,276
+207,651
+161% +$7.65M
CSLT
723
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$12M 0.01%
788,411
-8,762
-1% -$142K
CYT
724
DELISTED
CYTEC INDS INC
CYT
$12M 0.01%
226,834
SBY
725
DELISTED
Silver Bay Realty Trust Corp.
SBY
$11.9M 0.01%
728,832
+6,086
+0.8% +$94.8K

Similar funds

BlackRock Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors's Q2 2014 filing shows 177 new, 783 increased, 2,146 reduced and 145 closed positions. Its largest new stake was iShares US Financials ETF: 3,120,594 shares worth $130M. The largest sale was Pfizer, an estimated $281M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.

  • BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
  • BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
  • BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
  • BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
  • BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
  • BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.

Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.